DNP Signs PS Agreement, Adds CLA Capsules

WHITTIER, Calif.—DNP International announced it signed an “exclusive contract with China’s only manufacturer of phosphatidylserine” (PS). According to the company, the move will allow DNP to “corner the market” on PS. David Ji, president of DNP, said, “Our customers can continue to enjoy DNP’s competitive prices on [PS] with the added benefit of having it come from a steady Chinese source.”

In additional news, DNP added its first finished product, conjugated linoleic acid (CLA) capsules, which Ji said would strengthen the company’s inventory and minimize costs to its customers. “This finished product will eliminate the need to spend precious time and energy on formulation and encapsulation; the CLA capsules can be bottled and labeled immediately,” he added.